Assignee
TEKMIRA PHARMACEUTICALS CORP
CA4 patents
Top patents by PatentIndex Score
US9345780B2May 24, 2016
Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
TEKMIRA PHARMACEUTICALS CORP255 citations99
US9394234B2Jul 19, 2016
Lipid formulations
TEKMIRA PHARMACEUTICALS CORP117 citations98
US7811602B2Oct 12, 2010
Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
TEKMIRA PHARMACEUTICALS CORP95 citations95
US7244448B2Jul 17, 2007
Liposomal antineoplastic drugs and uses thereof
TEKMIRA PHARMACEUTICALS CORP22 citations90